logo
Plus   Neg
Share
Email

Dassault Systemes Q4 Profit Down - Quick Facts

Dassault Systemes SA (DASTY.PK), a French developer of 3D design software, reported that its fourth-quarter net income attributable to equity holders of the parent declined to 99.4 million euros from last year's 108.1 million euros, with earnings per share decreasing to 0.39 euros from 0.43 euros in the same quarter last year.

But, non-IFRS earnings per share were 0.58 euros, up from 0.51 euros in the previous year.

Total revenue for the quarter grew to 673.2 million euros from 565.4 million euros in the prior year. Organic new licenses revenue were up 12% in fourth quarter.

Thibault de Tersant, Senior Executive Vice President, CFO, commented,"The fourth quarter well concluded a gratifying year. We benefited progressively from broad-based strengthening of our performance from both a geographic and industry perspectives - with satisfactory diversification and, at the same time, very good traction in Transportation & Mobility.

For the first quarter 2014, the company expects non-IFRS total revenue objective of about 610 million euros - 620 million euros based upon the exchange rates assumptions, representing a variation of about 15% to 17% excluding currency effects, and non-IFRS earnings per share of about 0.38 euros.

For 2015, the company expects non-IFRS revenue growth objective range of about 11% to 12% in constant currencies or 2.700 billion euros to 2.720 billion euros based upon the 2014 currency exchange rate assumptions.

The company anticipates 2014 non-IFRS earnings per share range of about 2.04 euros to 2.09 euros, representing a growth objective range of 12% to 15%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. U.S. President Donald Trump has issued executive orders to ban Chinese mobile application TikTok as well as WeChat, citing a threat to national security and its economy. China's ByteDance Ltd. owns TikTok, a video-sharing mobile app, while Tencent Holdings Ltd. owns WeChat, a messaging, social media, and electronic payment app.
Follow RTT